The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver

American Journal of Gastroenterology

Volumn 102, Issue 8, 2007, Pages 1654-1659

  Byrnes, Valerie ^a   Shi, Hongyu ^a   Kiryu, Shigeru ^a   Rofsky, Neil M ^a   Afdhal, Nezam H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDIES;

EID: 34547641944     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01338.x     Document Type: Article

References (29)

1. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 1997 112 : 463 72.
2. Figueras J, Jaurrieta E, Valls C, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy. J Am Coll Surg 2000 190 : 580 7.
3. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 334 : 693 9.
4. Yamashita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patients with chronic liver damage: Prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996 200 : 79 84.
5. Rode A, Bancel B, Douek P, et al. Small nodule detection in cirrhotic livers: Evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001 25 : 327 36.
6. Krinsky GA, Theise ND, Rofsky NM, et al. Dysplastic nodules in cirrhotic liver: Arterial phase enhancement at CT and MR imaging-a case report. Radiology 1998 209 : 461 4.
7. Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol 2002 12 : 753 64.
8. Kanematsu M, Kondo H, Semelka RC, et al. Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver. Clin Radiol 2003 58 : 778 86.
9. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: Prospective diagnosis with MR imaging and explantation correlation. Radiology 2001 219 : 445 54.
10. Baron RL, Peterson MS. From the RSNA refresher courses: Screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: Opportunities and pitfalls. Radiographics 2001 21 : S117 32.
11. Yu JS, Kim KW, Sung KB, et al. Small arterial-portal venous shunts: A cause of pseudolesions at hepatic imaging. Radiology 1997 203 : 737 42.
12. Yu JS, Kim KW, Jeong MG, et al. Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 2000 217 : 750 6.
13. Ito K, Mitchell DG, Hann HW, et al. Viral-induced cirrhosis: Grading of severity using MR imaging. AJR Am J Roentgenol 1999 173 : 591 6.
14. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005 42 : 1208 36.
15. Earls JP, Rofsky NM, DeCorato DR, et al. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: Optimization with a test examination and a power injector. Radiology 1997 202 : 268 73.
16. Yu JS, Kim YH, Rofsky NM. Dynamic subtraction magnetic resonance imaging of cirrhotic liver: Assessment of high signal intensity lesions on nonenhanced T1-weighted images. J Comput Assist Tomogr 2005 29 : 51 8.
17. Shimizu A, Ito K, Koike S, et al. Cirrhosis or chronic hepatitis: Evaluation of small (< or = 2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003 226 : 550 5.
18. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: Evaluation and comparison with whole explanted liver. Radiology 2005 237 : 938 44.
19. Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: Clinical implications. AJR Am J Roentgenol 2002 178 : 1327 34.
20. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999 212 : 876 84.
21. Kim TK, Choi BI, Han JK, et al. Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: Two-phase spiral CT findings. Radiology 1998 208 : 597 603.
22. Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol 2004 20 : 254 63.
23. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 1986 90 : 289 98.
24. Chalasani N, Said A, Ness R, et al. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: Results of a national survey. Am J Gastroenterol 1999 94 : 2224 9.
25. Livraghi T, Bolondi L, Buscarini L, et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol 1995 22 : 522 6.
26. Kubota K, Ina H, Okada Y, et al. Growth rate of primary single hepatocellular carcinoma: Determining optimal screening interval with contrast-enhanced computed tomography. Dig Dis Sci 2003 48 : 581 6.
27. Hussain HK, Syed I, Nghiem HV, et al. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 2004 230 : 637 44.
28. Marrero JA, Hussain HK, Nghiem HV, et al. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005 11 : 281 9.
29. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001 35 : 421 30.